Chemoinformaics analysis of 6,7-Dehydroferruginol
| Molecular Weight | 284.443 | nRot | 1 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 16 |
| Exact Molecular Weight | 284.214 | nRing | 3 |
| Solubility: LogS | -5.909 | nHRing | 0 |
| Solubility: LogP | 5.934 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 52.8722 |
| nHD | 1 | BPOL | 28.0898 |
| QED | 0.709 |
| Synth | 3.789 |
| Natural Product Likeliness | 2.603 |
| NR-PPAR-gamma | 0.037 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.993 |
| Pgp-sub | 0.003 |
| HIA | 0.009 |
| CACO-2 | -4.994 |
| MDCK | 0.0000166 |
| BBB | 0.097 |
| PPB | 0.983063 |
| VDSS | 4.413 |
| FU | 0.0266438 |
| CYP1A2-inh | 0.589 |
| CYP1A2-sub | 0.764 |
| CYP2c19-inh | 0.582 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.365 |
| CYP2c9-sub | 0.872 |
| CYP2d6-inh | 0.796 |
| CYP2d6-sub | 0.807 |
| CYP3a4-inh | 0.753 |
| CYP3a4-sub | 0.613 |
| CL | 10.089 |
| T12 | 0.072 |
| hERG | 0.524 |
| Ames | 0.028 |
| ROA | 0.477 |
| SkinSen | 0.918 |
| Carcinogencity | 0.474 |
| EI | 0.903 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.832 |
| Antiviral | No |
| Prediction | 0.813802 |